SAN DIEGO, Jan. 19, 2011 /PRNewswire/ — Santarus, Inc.
(Nasdaq: SNTS) announces that a live audio webcast and
accompanying slide presentation will be provided for its Analyst
Day and Investor Briefing.
Details of the event are as follows:What:Santarus Analyst Day
and Investor BriefingWhen:Today, Wednesday, January 19, 2011 at
4:15 p.m. Eastern timeWhere:www.santarus.com (under
the Investor Relations link)AGENDA
Strategic Overview and 2011 Financial Outlook
Gerald T. Proehl, President, Chief Executive Officer &
Director, Santarus, Inc.
CYCLOSET® – Clinical/Medical Background
Dr. J. Michael Gaziano, Chief, Division of Aging, Brigham &
Women’s Hospital,
Professor of Medicine, Harvard Medical School
ULTESA™ (Budesonide MMX®) – Overview and Top-line
Phase III Clinical Study Results
Dr. Simon P.L. Travis, Consultant Gastroenterologist,
Translational Gastroenterology Unit, John Radcliffe Hospital,
Oxford, UK
Ulcerative Colitis – Treatment Perspective
Dr. William J. Sandborn, Professor of Clinical Medicine and Chief
of the Division of Gastroenterology,
University of California, San Diego
RHUCIN® and Hereditary Angioedema (HAE)
Dr. Bruce L. Zuraw, Professor of Medicine and Chief, Allergy and
Immunology, University of California, San Diego,
Research Scientist, San Diego VA Healthcare
SAN-300 (anti-VLA-1 antibody)
Dr. Mark C. Totoritis, Senior Vice President, Biologics, Santarus,
Inc.
Wrap-up/Question & Answer Session
Gerald T. Proehl, President, Chief Executive Officer &
Director, Santarus, Inc.
How:Live over the Internet – Simply log on t
‘/>”/>
